FDA Targets Stem Cell Clinics In California Offering Pricey, But Unproven, Treatments
The clinics have largely avoided regulation because they use stem cells from their patients' own bodies, but critics call the therapies dangerous quackery. “It’s a huge, unapproved human experiment,” said Paul Knoepfler, a stem cell researcher at the University of California at Davis.
FDA Crackdown Could Shut Stem Cell Clinics Peddling Unproven Treatments
Federal regulators are preparing to crack down on scores of clinics across the United States that offer pricey stem cell therapies for conditions ranging from autism to multiple sclerosis to erectile dysfunction without any scientific evidence that they work. (McFarling, 2/8)